Results 111 to 120 of about 7,902 (191)

Bioequivalence evaluation of two amlodipine salts, besylate and orotate, each in a fixed-dose combination with olmesartan in healthy subjects

open access: yesDrug Design, Development and Therapy, 2015
Soo-Yun Lee,1 Jung-Ryul Kim,2,3 Jin Ah Jung,4 Wooseong Huh,2,5 Mi Young Bahng,6 Jae-Wook Ko1,2 1Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea; 2Department of Clinical Pharmacology and ...
Lee SY   +5 more
doaj  

A PROSPECTIVE STUDY TO ANALYSE THE SIDE EFFECTS OF OLMESARTAN MEDOXOMIL AND ENALAPRIL IN HYPERTENSIVE SUBJECTS [PDF]

open access: yes, 2018
Objective: The present study was aimed to analyze the side effects of olmesartan medoxomil and enalapril in hypertensive subjects.Methods: The study consisted of newly diagnosed hypertension categorized according to 7th report of Joint National ...
Singh, Parminderpal, Kiranjit, Kiranjit
core  

EFFECT OF ANGIOTENSIN RECEPTOR BLOCKADE ON ENDOTHELIAL FUNCTION: FOCUS ON OLMESARTAN MEDOXOMIL

open access: yesРоссийский кардиологический журнал, 2010
Endothelial dysfunction is the common link between cardiovascular disease risk factors and the earliest event in the cascade of incidents that results in target organ damage.
C. Ferrario
doaj  

Supplementary Material for: Severe hepatitis complicating olmesartan enteropathy

open access: yes
Introduction: Olmesartan, an angiotensin II receptor antagonist, is associated with an uncommon complication of enteropathy that presents insidiously, usually months to years after initial commencement of anti-hypertensive therapy which can be dose ...
Tabatabai S. (18306649)   +5 more
core   +1 more source

Ramipril and Olmesartan: Unveiling their pleiotropic potential as immunomodulators. [PDF]

open access: yesIndian J Pharmacol
Dasan J   +4 more
europepmc   +1 more source

Blood pressure lowering efficacy of sacubitril/allisartan versus olmesartan in elderly Chinese hypertensive patients. [PDF]

open access: yesJ Geriatr Cardiol
Zhang W   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy